Nanosized bimetallic PtMo, PtFe and trimetallic PtMoSn catalysts deposited on highly dispersed carbon black Vulcan XC-72 were synthesized from the cluster complex compounds PtCl(P(C6H5)3)(C3H2N2(CH3)2)Mo(C5H4CH3)(CO)3, Pt(P(C6H5)3)(C3N2H2(CH3)2)Fe(CO)3(COC6H5C2C6H5), and PtCl(P(C6H5)3)(C3N2H2(CH3)2)C5H4CH3Mo(CO)3SnCl2, respectively. Structural characteristics of these catalysts were studied using X-ray diffraction (XRD), microprobe energy dispersive spectroscopy (EDX), and transmission electron microscopy (TEM). The synthesized catalysts were tested in aqueous 0.5 M H2SO4 in a three-electrode electrochemical cells and in single fuel cells. Electrocatalytic activity of PtMo/C and PtFe/C in the oxygen reduction reaction (ORR) and the activity of PtMoSn/C in electrochemical oxidation of ethanol were evaluated. It was shown that specific characteristics of the synthesized catalysts are 1.5–2 times higher than those of a commercial Pt(20%)/C catalyst. The results of experiments indicate that PtFe/C, PtMo/C, and PtMoSn/C catalysts prepared from the corresponding complex precursors can be regarded as promising candidates for application in fuel cells due to their high specific activity.
This research is focused on the adsorption modification of detonation nanodiamond surfaces with antibiotics for their further use as smart materials for cardiovascular surgery purposes, namely as bioprostheses modifiers. Tritium-labeled amikacin and levofloxacin were used as tracers for the adsorption process control. We found that nanodiamonds form adsorption complexes with levofloxacin via physical adsorption, while in the case of amikacin, electrostatic attraction contributes to the formation of more stable complexes, even in the presence of electrolytes and desorbing agents (models of biological fluids). Antimicrobial characterization of nanodiamond–levofloxacin and nanodiamond–amikacin complexes indicates a reduction in the dose of antibiotics that is used as an antimicrobial agent. Therefore, the use of biomaterial based on DND complexes with antibiotics as the basis of bioprostheses will allow one either to avoid or significantly reduce the duration and intensity of antibiotics use in the postoperative period, which is critically important from the viewpoint of the development of antibiotic resistance in pathogens.